Clinicopathologic and Molecular Analysis of a Choroidal Pigmented Schwannoma in the Context of a PTEN Hamartoma Tumor Syndrome
Authors:
- Alexandre P. MoulinAMAlexandre P. Moulin
- Manuel DeprezMDManuel Deprez
- Sylvie UfferSUSylvie Uffer
- Armand BottaniABArmand Bottani
- Leonidas ZografosLZLeonidas Zografos
- Carlo RivoltaCRCarlo Rivolta
- 1 April 2012
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 119 (4) , 857-864
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320000-121929)
This publication has 44 references indexed in Scilit:
- PTEN Level in Tumor Suppression: How Much Is Too Little?Cancer Research, 2011
- MicroRNA-21 Overexpression Contributes to Vestibular Schwannoma Cell Proliferation and SurvivalOtology & Neurotology, 2010
- Subtle variations in Pten dose determine cancer susceptibilityNature Genetics, 2010
- Merlin Knockdown in Human Schwann CellsOtology & Neurotology, 2010
- PTEN hamartoma tumor syndrome: An overviewGenetics in Medicine, 2009
- Choroidal schwannomaActa Ophthalmologica Scandinavica, 2005
- Class reunion: PTEN joins the nuclear crewOncogene, 2005
- Pten Dose Dictates Cancer Progression in the ProstatePLOS Biology, 2003
- Lhermitte–Duclos disease is a clinical manifestation of Cowden’s syndromeSurgical Neurology, 2001
- Lhermitte-Duclos disease and Cowden's syndrome in an adolescent patientJournal of Neurosurgery, 1994